Triveni Bio is pioneering a genetics-informed precision medicine approach to develop functional antibodies to treat immunological and inflammatory disorders.
Location: United States, Massachusetts, Waltham
Total raised: $207M
Investors 2
| Date | Name | Website |
| 18.11.2023 | OrbiMed | orbimed.co... |
| 26.10.2023 | Atlas Vent... | atlasventu... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.10.2024 | Series B | $115M | - |
| 26.10.2023 | Series A | $92M | - |
Mentions in press and media 3
| Date | Title | Description |
| 04.10.2024 | Triveni Bio: $115 Million (Series B) Closed To Advance Novel Antibody Treatments For I&I Disorders | Triveni Bio, a biotech company advancing novel antibody treatments for I&I disorders, announced a $115 million Series B to support pipeline expansion. The funding round was led by Goldman Sachs Alternatives with significant participatio... |
| 26.10.2023 | Triveni Bio Raises $92M in Series A | Triveni Bio, a Waltham, MA-based biotech company providing a genetics-informed precision medicine approach for I&I disorders, raised $92M in Series A funding. The round was led by Atlas Venture and Cormorant Asset Management, with parti... |
| - | Triveni Bio | “Triveni Bio is pioneering a genetics-informed precision medicine approach to develop functional antibodies to treat immunological and inflammatory disorders.” |